Current Treatment Paradigms for Locally Advanced Non-small Cell Lung Cancer-Reference-Cited by-同舟云学术

Current Treatment Paradigms for Locally Advanced Non-small Cell Lung Cancer

Published:2007-06 Issue:6 Volume:2 Page:S77-S85
ISSN:1556-0864
Container-title:Journal of Thoracic Oncology
language:en
Short-container-title:Journal of Thoracic Oncology

Author:

Rigas James R,Kelly Karen

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine,Oncology

Reference56 articles.

1. Clinical features of 5,628 primary lung cancer patients: experience at Mayo Clinic from 1997 to 2003;Yang;Chest,2005

2. Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small-cell lung cancer;Arriagada;N Engl J Med,2004

3. Adjuvant vinorelbine plus cisplatin versus observation in patients with completely resected stage IB–IIIA non-small-cell lung cancer (Adjuvant Navelbine International Trialist Association [ANITA]): a randomised controlled trial;Douillard;Lancet Oncol,2006

4. Impact of radiation on survival after complete resection of non-small-cell lung cancer: descriptive analysis in the randomized adjuvant chemotherapy trial, ANITA 1;Douillard;Int J Radiat Oncol Biol Phys,2006

5. Bcl2 phosphorylation and p27 induction as potential p53-independent mechanisms of apoptotic responses to taxanes in non-small cell lung carcinoma (NSCLC);Gumerlock;Proc Am Assoc Cancer Res,1999

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Racial Differences in Treatments and Toxicity in Patients With Non–Small-Cell Lung Cancer Treated With Thoracic Radiation Therapy;JCO Oncology Practice;2022-06

2. Major pulmonary resection after neoadjuvant chemotherapy or chemoradiation in potentially resectable stage III non-small cell lung carcinoma;Scientific Reports;2021-10-12

3. Perioperative alectinib in a patient with locally advanced anaplastic lymphoma kinase positive non-small cell lung cancer (NSCLC): a case report;Translational Cancer Research;2021-08

4. Perioperative crizotinib in a patient with stage IIIB ALK-positive non-small cell lung cancer: a case report;Annals of Translational Medicine;2020-06

5. Neoadjuvant Crizotinib in Resectable Locally Advanced Non–Small Cell Lung Cancer with ALK Rearrangement;Journal of Thoracic Oncology;2019-04